Alawadhi E, et al. - Using data from the Kuwait Cancer Registry, researchers evaluated the distribution of stage at diagnosis for 12 cancers (including oesophagus, stomach, colon, rectum, liver, pancreas, lung, melanoma, breast (women), cervix, ovary, and prostate) in Kuwait. They also estimated stage-specific net survival at 1 and 5 years following diagnosis, as well as focused on disparities in stage-specific survival between Kuwait and the United States. They found that diagnosis was received by 14.2% and 38.9% of patients at a localised stage and at the regional stage, respectively. During 2000–2004, 88.9% of patients had a known stage; this value declined to 59.4% during 2010–2013. Approximately 90% or higher 1- and 5-year survival was reported for colon, rectal, breast, cervical, and prostate cancer for patients diagnosed at the localised stage during 2005–2009. A similar stage-specific survival was reported in Kuwait and the US, and therefore, a possible major contributor to the overall lower survival in Kuwait vs the US was late stage at diagnosis. In order to attenuate the proportion of patients diagnosed at a late stage and to enhance survival, it is important to improve public awareness of cancer risk factors and symptoms and to invest in early detection.